Abstract | OBJECTIVES: We sought to investigate the anti-staphylococcal activity of indolmycin, with particular emphasis on comparing its activity with fusidic acid and mupirocin. METHODS: Established procedures were used to examine the activity of indolmycin against a range of clinical isolates, including strains resistant to fusidic acid and mupirocin. Indolmycin-resistant mutants were recovered and characterized phenotypically and genotypically. RESULTS: CONCLUSIONS:
|
Authors | Julian G Hurdle, Alex J O'Neill, Ian Chopra |
Journal | The Journal of antimicrobial chemotherapy
(J Antimicrob Chemother)
Vol. 54
Issue 2
Pg. 549-52
(Aug 2004)
ISSN: 0305-7453 [Print] England |
PMID | 15243028
(Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Anti-Infective Agents, Local
- Indoles
- Fusidic Acid
- Mupirocin
- Tryptophan-tRNA Ligase
- indolmycin
|
Topics |
- Anti-Infective Agents, Local
(pharmacology)
- Drug Resistance, Bacterial
- Fusidic Acid
(pharmacology)
- Geobacillus stearothermophilus
(drug effects, enzymology, genetics)
- Indoles
(pharmacology)
- Mupirocin
(pharmacology)
- Staphylococcal Infections
(microbiology)
- Staphylococcus aureus
(drug effects, enzymology, genetics)
- Tryptophan-tRNA Ligase
(metabolism)
|